<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03742089</url>
  </required_header>
  <id_info>
    <org_study_id>C52</org_study_id>
    <nct_id>NCT03742089</nct_id>
  </id_info>
  <brief_title>Evaluation of the BHX Implant in Children With a BAHS</brief_title>
  <official_title>Evaluation of Implant Stability and Audiological Benefit of Oticon Medicals BHX Implant in Children Undergoing Surgery for a Percutaneous Bone Anchored Hearing System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oticon Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oticon Medical</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to in a proactive manner collect high quality data from&#xD;
      pediatric patients who have undergone a bone anchored hearing surgery, using the Ponto BHX&#xD;
      implant, in clinical practice. This to further increase the knowledge of bone anchored&#xD;
      hearing systems in the pediatric population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2018</start_date>
  <completion_date type="Anticipated">May 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Implant stability</measure>
    <time_frame>6 months post surgery</time_frame>
    <description>Implant stability will be assessed using resonance frequency analysis (RFA). This is a non-invasive technique using a SmartPeg (no 55) introduced into the abutment top. A probe is directed to the SmartPeg measuring the vibrations as a test for the stability of the interface between the fixture and the bone (osseointegration). The measurement renders Implant Stability Quotient (ISQ) 'numerical values from 1 to 100'; the higher the ISQ value, the higher the stability. Two perpendicular measurements will be performed at each site. The highest and lowest ISQ value obtained at each time point aree recorded. The Osstell ISQ instrument and SmartPegs from Osstell (Gothenburg, Sweden) will be used. Difference in mean of ISQ low at 6 months compared to surgery.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hearing Loss, Conductive</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <description>Bone Anchored Hearing Surgery using a BHX implant manufactured by Oticon Medical</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bone Anchored Hearing Surgery</intervention_name>
    <description>This is a observational study of pediatric patients undergoing bone anchored hearing surgery. The collected will be used to assess the implant stability development of the Ponto BHX implant during up to 24 months after implantation in a pediatric population undergoing BAHS. The study will also monitor the Ponto BHX implant safety and survival throughout the study period.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric population eligible for a bone anchored hearing surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients who have decided to undergo a Bone Anchored Hearing Surgery and receive a&#xD;
             Ponto system.&#xD;
&#xD;
          2. Signed informed consent.&#xD;
&#xD;
          3. Patients between 5 - 16 years of age.&#xD;
&#xD;
          4. Patients eligible for one stage surgery.&#xD;
&#xD;
          5. Patients who have been using Ponto sound processor on a soft band for at least 2&#xD;
             weeks.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who cannot attend follow up visits.&#xD;
&#xD;
          2. Patients with single side deafness (SSD).&#xD;
&#xD;
          3. In surgeon's opinion, any other disorder and condition that may deem the patient unfit&#xD;
             to participate in the study.&#xD;
&#xD;
          4. Patients who receive other implant than the Ponto BHX.&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Sukhi Singh, PhD</last_name>
    <phone>0046734219323</phone>
    <email>suin@oticonmedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aniravan Banerjee, MS, FRCSed</last_name>
      <phone>+44 1642 854046</phone>
      <email>Anirvan.Banerjee@stees.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Lisa Kennedy</last_name>
      <phone>+44 7853 138296</phone>
      <email>Lisa.Kennedy@stees.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Aniravan Banerjee, MS, FRCEed</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>November 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2018</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Hearing Loss, Conductive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

